a stock i profiled some years ago also worked in this 'seed' area as described here in this release (below) from INIS. Stock was NASI...went from around 2.75 at the time i profiled it up to about 60 then forward split 3 for 2 and ran again to 50. It was the best performing stock of any i had ever done up until POCI or SCKT last year.
those were the days <GGGGGGGGG>
gpg
International Isotopes Inc Announces Progress in
Iodine-125 Seed Production and Sales
DENTON, Texas--(BW HealthWire)--Aug. 17, 2000--International Isotopes Inc (Nasdaq/NMS:INIS - news; BSE:ITL)
(I3) announces progress in building a fully automated seed production process.
Currently in full production are three robotic welding and loading units. A fourth welding and loading unit will be operational in
August. The next step to be automated is the seed assay, or testing process. In the past this process has been entirely manual.
Two fully robotic seed assay systems are undergoing qualification in the manufacturing facility and are expected to be in
production shortly. A computerized camera system for counting the seeds is expected to be qualified and in production by the
end of the quarter. The automated seed production process has resulted in a steady increase in output and revenues. Seed sales
in July were 30% over those in June and August sales are expected to be 60% higher than July. Current third quarter revenues
from Iodine-125 seeds have increased 213% over the comparable second quarter revenues.
The company also announces continued progress in expanding seed distribution channels. Agreements have been reached with
several radiopharmacies, including Custom Care Pharmacy and Eastern Isotopes, to promote the Iodine-125 seed. Efforts are
underway to obtain the CE mark to begin sales and marketing in Europe.
David M. Camp, President and CEO, said, ``The challenge of automating this process has been difficult. With the addition of
our fourth welding unit, the seed assay units and the counting system, our dedicated effort has truly begun to pay off. We expect
to see continued, steady growth in production and sales over the next couple of quarters. We are running a seven-day, multiple
shift operation to keep up with current demand while installing the automated system. I am very proud of the incredible
sacrifices that our people are making. It is this kind of dedication that builds successful companies.''
About International Isotopes Inc
International Isotopes Inc. is initiating production operations to be the premier supplier of finished radiopharmaceuticals,
pharmaceutical grade radiochemicals, radioisotopes and brachytherapy devices used in nuclear medicine for the diagnostic and
therapeutic treatment of cancer and other diseases.
For More Company Information, Please Visit I3's web site at: www.internationalisotopes.com
International Isotopes Safe Harbor Statement
Statements in the press release may constitute forward-looking statements and are subject to numerous risks and uncertainties,
including the ability to meet time schedules, the need to raise additional capital, the development of competitive products by
others and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. The
Company disclaims any obligation to update statements in this press release.
Contact:
International Isotopes Inc, Denton
David Camp, President and CEO
Paul Landers, Chief Financial Officer
940/323-2613
or
Public/Investor Relations
Jim Drewitz, 972/355-6070 |
